Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01815567 · ClinicalTrials.gov registry record

DETECT and Retinal Outcomes in Hypertension

A clinical trial of Hypertension and Cognitive Impairment, sponsored by Emory University.

Completed
Registry status
234
Enrollment target
1
Study location

NCT01815567: Completed study of Hypertension and Cognitive Impairment, sponsored by Emory University.

NCT01815567 is a study of Hypertension and Cognitive Impairment that has completed, run by Emory University. The registered enrollment target is 234 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01815567, a study of Hypertension and Cognitive Impairment, has completed, sponsored by Emory University.

COMPLETED
Registry status
234 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to study the impact of blood pressure on cognitive performance.

Primary Outcome

We aim to determine the correlation (if any) between the severity of blood pressure and DETECT neurocognitive outcomes as well as the correlation (if any) between known Hypertensive retinal disease and DETECT neurocognitive outcomes. Appropriate statistical analysis will be performed to compare clinical retinal findings, BP values, and DETECT neurocognitive test outcomes. Subject level data will only be collected on the day of Emergency Department presentation. Subjects will not be followed aft

Study Locations (1)

Georgia

  • Grady Memorial Hospital - Atlanta

Trial Details

FieldValue
Enrollment Target 234 participants
Start Date 2012-11
Est. Completion 2020-07-15
Emory University

1,208 total trials

What the finished NCT01815567 record still lists

NCT01815567 is an observational study that tracks outcomes without assigning an intervention. The registered 234 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (93% lower).

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 0 interventions.

NCT01815567 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT01815567 about?

NCT01815567 is a clinical study titled "DETECT and Retinal Outcomes in Hypertension". The purpose of this study is to study the impact of blood pressure on cognitive performance.

What is the current status of trial NCT01815567?

This trial is currently completed. The enrollment target is 234 participants. The study started on 2012-11. Estimated completion is 2020-07-15.

What conditions does trial NCT01815567 study?

This clinical trial studies the following conditions: Hypertension, Cognitive Impairment, Retinal Disorder.

Who is sponsoring clinical trial NCT01815567?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01815567 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01815567's enrollment target sits among peer trials

234 202nd of 470 higher than 269 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04942717 · 234 participants · NA

    Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values

  • NCT05208671 · 234 participants · NA

    Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma

  • NCT05444465 · 234 participants · NA

    Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears

  • NCT05720338 · 234 participants · Phase 3

    Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01815567, the US trial registry maintained by the National Library of Medicine. NCT01815567 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.